1021438-60-7

Basic information

• Product Name: (3R,5S,8S)-8-cyclohexyl-18-methoxy-13,13-dimethyl-7,10-dioxo-22-(2-phenylethyl)-2,11-dioxa-6,9,21-triazatetracyclo[15.6.2.1(3,6).0(20,24)]hexacosa-1⁽²³⁾,17,19,21,24-pentaene-5-carboxylic acid
• Synonyms: (3R,5S,8S)-8-cyclohexyl-18-methoxy-13,13-dimethyl-7,10-dioxo-22-(2-phenylethyl)-2,11-dioxa-6,9,21-triazatetracyclo[15.6.2.1(3,6).0(20,24)]hexacosa-1⁽²³⁾,17,19,21,24-pentaene-5-carboxylic acid
• CAS NO: 1021438-60-7
• Molecular Weight: 671.834
• Mol File: 1021438-60-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (3R,5S,8S)-8-cyclohexyl-18-methoxy-13,13-dimethyl-7,10-dioxo-22-(2-phenylethyl)-2,11-dioxa-6,9,21-triazatetracyclo[15.6.2.1(3,6).0(20,24)]hexacosa-1⁽²³⁾,17,19,21,24-pentaene-5-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (3R,5S,8S)-8-cyclohexyl-18-methoxy-13,13-dimethyl-7,10-dioxo-22-(2-phenylethyl)-2,11-dioxa-6,9,21-triazatetracyclo[15.6.2.1(3,6).0(20,24)]hexacosa-1⁽²³⁾,17,19,21,24-pentaene-5-carboxylic acid(1021438-60-7)
• EPA Substance Registry System: (3R,5S,8S)-8-cyclohexyl-18-methoxy-13,13-dimethyl-7,10-dioxo-22-(2-phenylethyl)-2,11-dioxa-6,9,21-triazatetracyclo[15.6.2.1(3,6).0(20,24)]hexacosa-1⁽²³⁾,17,19,21,24-pentaene-5-carboxylic acid(1021438-60-7)

Safety Data

• Hazardous Substances Data: 1021438-60-7(Hazardous Substances Data)

Upstream product

• 1021437-95-5 methyl (2R,4S,7S)-7-cyclohexyl-23-methoxy-12,12-dimethyl-6,9-dioxo-20-{[(trifluoromethyl)sulfonyl]oxy}-3,4,6,7,8,9,12,13,14,15-decahydro-2H,11H-16,18-etheno-2,5-methanopyrido[4,3-k][1,10,3,6]dioxadiazacyclononadecine-4-carboxylate 
• 6783-05-7 trans-2-phenylvinylboronic acid 

Relevant articles and documents

HCV NS3 PROTEASE INHIBITORS

The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections. (I)